Lmr Partners LLP Tango Therapeutics, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$6.52 - $12.01 $71,720 - $132,110	-11,000 Reduced 44.0%	14,000 $138,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $8.29 $28,388 - $69,014	8,325 Added 49.93%	25,000 $181,000
Q2 2022 Aug 15, 2022	SELL	$3.86 - $8.01 $32,134 - $66,683	-8,325 Reduced 33.3%	16,675 $76,000
Q1 2022 May 16, 2022	SELL	$7.01 - $10.94 $94,347 - $147,241	-13,459 Reduced 35.0%	25,000 $190,000
Q4 2021 Feb 14, 2022	BUY	$9.55 - $14.29 $367,283 - $549,579	38,459 New	38,459 $421,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $345M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.